Document is current
Any future updates will be listed below
-
Authors
Xu, Yu https://orcid.org/0000-0002-7304-5045
Ritchie, Scott C. https://orcid.org/0000-0002-8454-9548
Liang, Yujian
Timmers, Paul R. H. J. https://orcid.org/0000-0002-5197-1267
Pietzner, Maik https://orcid.org/0000-0003-3437-9963
Lannelongue, Loïc https://orcid.org/0000-0002-9135-1345
Lambert, Samuel A. https://orcid.org/0000-0001-8222-008X
Tahir, Usman A.
May-Wilson, Sebastian https://orcid.org/0000-0003-2668-5717
Foguet, Carles https://orcid.org/0000-0001-8494-9595
Johansson, Åsa https://orcid.org/0000-0002-2915-4498
Surendran, Praveen
Nath, Artika P.
Persyn, Elodie https://orcid.org/0000-0001-9104-1972
Peters, James E. https://orcid.org/0000-0002-9415-3440
Oliver-Williams, Clare
Deng, Shuliang
Prins, Bram https://orcid.org/0000-0001-5774-034X
Luan, Jian’an https://orcid.org/0000-0003-3137-6337
Bomba, Lorenzo
Soranzo, Nicole https://orcid.org/0000-0003-1095-3852
Di Angelantonio, Emanuele
Pirastu, Nicola
Tai, E. Shyong https://orcid.org/0000-0003-2929-8966
van Dam, Rob M.
Parkinson, Helen
Davenport, Emma E.
Paul, Dirk S. https://orcid.org/0000-0002-8230-0116
Yau, Christopher https://orcid.org/0000-0001-7615-8523
Gerszten, Robert E. https://orcid.org/0000-0002-6767-7687
Mälarstig, Anders https://orcid.org/0000-0003-2608-1358
Danesh, John
Sim, Xueling https://orcid.org/0000-0002-1233-7642
Langenberg, Claudia https://orcid.org/0000-0002-5017-7344
Wilson, James F. https://orcid.org/0000-0001-5751-9178
Butterworth, Adam S. https://orcid.org/0000-0002-6915-9015
Inouye, Michael https://orcid.org/0000-0001-9413-6520
- License Information
-
More Information
Article History
Received: 29 April 2022
Accepted: 15 February 2023
First Online: 29 March 2023
Competing interests
: During the drafting of the manuscript, P.R.H.J.T. became a part-time employee of BioAge Labs, P.S. became a full-time employee of GSK and D.S.P. became a full-time employee of AstraZeneca. L.B. is an employee of BioMarin. J.D. serves on scientific advisory boards for AstraZeneca, Novartis and UK Biobank, and has received multiple grants from academic, charitable and industry sources outside of the submitted work. A.M. is an employee of Pfizer. A.S.B. reports institutional grants from AstraZeneca, Bayer, Biogen, BioMarin, Bioverativ, Novartis, Regeneron and Sanofi.
